Ibrance 125 mg/1

Ibrance 125 mg capsules are a prescription medication used in the treatment of certain types of cancer. This oral therapy is designed to target specific cells in the body, offering a targeted approach to cancer treatment.

Ibrance 125 mg capsules are primarily used in combination with other medications for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer. This medication is often prescribed to postmenopausal women who have not previously received endocrine-based therapy. The active ingredient, palbociclib, works by inhibiting the growth of cancer cells, making it a crucial component in the management of certain types of breast cancer.

Common effects of Ibrance 125 mg capsules may include fatigue, nausea, and a decrease in white blood cell counts. Some individuals may also experience hair thinning, diarrhea, and infections. These effects can vary in severity and duration, and it is important to discuss any concerns with a healthcare provider.

Ibrance 125 mg capsules should be handled with care, as they are designed for oral administration. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature, away from moisture and heat. Always consult with a healthcare provider before starting or stopping any medication.

Ibrance 125 mg capsules may interact with certain medications, including those that are metabolized by the liver. It is important to inform a healthcare provider about all medications, supplements, and herbal products being taken to avoid potential interactions. Additionally, alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy and safety of this medication.